Sign In
8 Sep 2014 18:21
Biofrontera AG
("Biofrontera" or the "Company")
Director Dealing
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that on 4 September 2014 Thomas Schaffer, the Chief Financial Officer of the Company, purchased a further 1,500 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at a price of EUR 2.347 per Ordinary Share. Subsequent to this transaction Mr Schaffer has a beneficial interest in 11,588 Ordinary Shares representing 0.05% of the issued ordinary share capital of the Company.
For further information, please contact:
Biofrontera AG
|
|
Prof. Hermann Lübbert, Chief Executive Officer Thomas Schaffer , Chief Financial Officer | Tel: + 49 (0) 214 - 87632 - 22
|
|
|
finnCap (Nomad and Broker) |
|
Geoff Nash / Christopher Raggett (Corporate Finance) | Tel: 020 7220 0500 |
Steven Norcross(Corporate Broking) |
|
|
|
Investor Relations |
|
Seton Services |
|
Toni Vallen | Tel: 020 7603 6797 |
|
|
Financial PR Gable Communications |
|
John Bick | Tel: 020 7193 7463 |
Follow the stocks
